富瑞金融:看好艾迪康(09860)AI战略布局和Crown Bioscience并购 予以“买入”评级目标价看高至12.6港元
Last Update:
26 1 月, 2026
Our site uses cookies. By using this site, you agree to the Privacy Policy and Terms of Use.